Diabetes Prediction in Scania - DiPiS

Diabetes Prediction in Scania (DiPiS) aims to determine why children develop type 1 diabetes. By being able to predict which children are at risk of developing diabetes, the hope is to prevent the onset of the disease in the future. DiPiS was conducted in two stages: Stage 1: Examination of the hereditary risk for type 1 diabetes in all newborns in Scania. This stage took place from September 2000 to September 2004. During this stage, almost 36,000 children were examined. Stage 2: Follow-up of a group of children with hereditary risk. Approximately 5,000 children were followed. Participants in the follow-up study provided blood samples once a year and also completed a questionnaire. Children with multiple antibodies are at an increased risk of developing type 1 diabetes and were therefore monitored more frequently. The children were followed until the age of 15. Objective: To determine factors that can predict autoimmune (type 1) diabetes in children.